BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv4.7.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.mdtechcouncil.com/membership/events
X-WR-CALDESC:Events for 
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230322T110000
DTEND;TZID=America/New_York:20230322T120000
DTSTAMP:20260415T093352
CREATED:20230307T140422Z
LAST-MODIFIED:20230307T140422Z
UID:3620-1679482800-1679486400@www.mdtechcouncil.com
SUMMARY:NIH Technology Opportunities Webinar: Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
DESCRIPTION:Register to attend a free NIH webinar. Attendees will learn about a new method for treating glaucoma using exosomes derived from bone marrow-derived mesenchymal stem cells (BMSC). The webinar will be presented by Dr. Stanislav Tomarev (Senior Investigator\, Retinal Ganglion Cell Biology\, NIH National Eye Institute) and Dr. Ben Mead (Neuroscientist\, Cardiff University Exosome and Retinal Research Group). \nWebinar overview:  \nThe inventors will discuss their discovery that BMSC‐derived exosome administration for glaucoma may confer a significant neuroprotective effect for retinal ganglion cells (RGCs) and prevent vision loss\, and how their isolated BMSC-derived exosomes have several immediate advantages for clinical translation compared to potential whole-cell (stem cell) therapies currently being used to treat glaucoma. \n
URL:https://www.mdtechcouncil.com/membership/events/calendar/nih-technology-opportunities-webinar-bone-marrow-mesenchymal-stem-cell-bmsc-derived-exosomes-for-the-treatment-of-glaucoma/
LOCATION:virtual\, United States
GEO:37.09024;-95.712891
END:VEVENT
END:VCALENDAR